Archive for the ‘MRSA / Drug Resistance’ Category
Wednesday, June 18th, 2008
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a cell therapy development and commercialization company, announced favorable safety and efficacy data for Tovaxin®, the Company's investigational T-cell vaccination therapy for multiple sclerosis (MS), in the second year of open-label clinical retreatment studies in patients with MS. The "intent to treat" population of 22 patients ...
Posted in MRSA / Drug Resistance | No Comments »
Wednesday, June 11th, 2008
In the first hearing of its kind, to be heard on Wednesday 11th June at the Royal Courts of Justice, an MS (Multiple Sclerosis) sufferer is challenging the Director of Public Prosecutions (DPP) to clarify the UK law on assisting the suicide of another person, in a country where it ...
Posted in MRSA / Drug Resistance | No Comments »
Wednesday, June 11th, 2008
The MS Society is among 18 major organisations to back a new report published, which reveals that rising care charges are putting older and disabled people at risk of not being able to afford to eat, heat, wash or get essential support. The report by the Coalition on Charging - ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, June 10th, 2008
A US drug company will seek marketing approval early next year for a drug which could improve mobility and quality of life for people with multiple sclerosis (MS).Acorda Therapeutics reported positive results following a second phase III clinical trial of the experimental drug Fampridine (4-aminopyridine) which showed improvement in ...
Posted in MRSA / Drug Resistance | No Comments »
Friday, June 6th, 2008
The MS Society is to launch a new initiative that aims to reassure carers of people with multiple sclerosis (MS) that their duties will still be carried out in an emergency.The free Carers Emergency Card gives 24-hour access to temporary cover for an unexpected situation and leaves the carers safe ...
Posted in MRSA / Drug Resistance | No Comments »
Thursday, June 5th, 2008
Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying on therapy, according to a new North American survey of people with MS, results of which were released today at ...
Posted in MRSA / Drug Resistance | No Comments »
Wednesday, June 4th, 2008
The European Commission has approved Extavia® (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) - the first in a new portfolio of medicines from Novartis that is planned to include both established treatments and innovative therapies for patients with MS. Extavia is the Novartis ...
Posted in MRSA / Drug Resistance | No Comments »
Friday, May 30th, 2008
The results of an international survey presentedby Bayer Schering Pharma shows that many people face the same fears andconcerns when they are first diagnosed with multiple sclerosis (MS). In thesurvey, 71 percent of people with MS had at least one concern about how thedisease would affect their relationships; 64 percent ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, May 27th, 2008
Italian researchers compared cognitive function between 63 children with MS and 57 controls without MS, and found significant impairment in about one-third of the children with MS. The study results highlight the need for early interventions - such as accommodations that can be made in school - to address cognitive ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, May 20th, 2008
On Saturday, May 10th, 2008 Mr. Lube Canada will be supporting the Multiple Sclerosis (MS) Society of Canada and MS Awareness Month by donating $5 from every oil change purchase at Mr. Lube locations across the country. Canada has one of the highest rates of MS in the world and ...
Posted in MRSA / Drug Resistance | No Comments »
Saturday, May 17th, 2008
Multiple sclerosis (MS) is, essentially, a failure to communicate. In a person with MS, the immune system has run amok, destroying the protective myelin coat that surrounds nerve cells. Without this myelin, messages cannot travel between the brain and the body as quickly as they can in a healthy person, ...
Posted in MRSA / Drug Resistance | No Comments »
Thursday, May 15th, 2008
Since 1948, the Multiple Sclerosis Society of Canada has led Canada to become one of the world's premier destinations for MS research and has improved hundreds of thousands lives through client care. These are just two reflections to consider during a May, MS Awareness Month. "The MS Society's 60 years ...
Posted in MRSA / Drug Resistance | No Comments »
Friday, April 11th, 2008
National multiple sclerosis charity the MS Trust has announced MS Awareness 2008 from 14th to 27th April. During MS Awareness, the Trust will be embarking on a number of high profile activities to demonstrate that you can embrace life with MS - with access to the right support and information, ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, April 8th, 2008
Leaky blood vessels that lose their ability to protect the spinal cord from toxins may play a role in the development of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, according to research published in the April issue of Nature Neuroscience.The results mark the first time that ...
Posted in MRSA / Drug Resistance | No Comments »
Tuesday, April 8th, 2008
Mice given caffeine equivalent to a human drinking six to eight cups of coffee a day were protected from developing experimental autoimmune encephalomyelitis (EAE), the animal model for the human disease Multiple Sclerosis (MS), according to researchers at Cornell University.Caffeine is a well-known adenosine receptor blocker, and the researchers believe ...
Posted in MRSA / Drug Resistance | No Comments »
